Accuragen's Series B Round

Accuragen raised a round of funding on June 01, 2016.

Accuragen has developed a high-sensitivity next-generation sequencing-based system for the detection of cancer mutations in minuscule concentrations of circulating cell-free DNA (cfDNA) in blood. The …

Articles about Accuragen's Series B Round: